
New Compound Excels at Killing Persistent and Drug-Resistant Tuberculosis LA JOLLA, CA June 17, 2013 An international team led by scientists at The Scripps Research Institute (TSRI), the Howard Hughes Medical Institute and Albert Einstein College of Medicine of Yeshiva University has identified a highly promising new anti-tuberculosis compound that attacks the tuberculosis (TB) bacterium in two different ways.
These findings represent an effort to help solve one of the major global health crises of our time the resurgence of TB and its dangerous drug-resistant strains, said Peter G. Schultz, the Scripps Family Chair Professor of Chemistry at TSRI, who was senior author of the study with William R. Jacobs, Jr., member of the Howard Hughes Medical Institute and professor of microbiology & immunology and of genetics at Albert Einstein College of Medicine.
In cell cultures and in mice, this compound showed powerful activity against ordinary active TB bacteria, non-replicating TB bacteria and even extensively drug-resistant TB strains, said Feng Wang, a member of the Schultz lab at TSRI and first author of the study with Dhinakaran Sambandan of the Jacobs lab and Rajkumar Halder of the Schultz lab.
The paper appears in this week online ahead of print in an Early Edition of the Proceedings of the National Academy of Sciences.
Global Health Crisis
Although isoniazid and rifampin, the two front-line TB drugs, came into use in 1952 and 1967 respectively, new TB infections still occur at the rate of roughly one per second. At any moment about a third of the existing human population is infected mostly with inactive, latent TB, although active TB still kills over one million people each year. Russia, Africa, China and Southeast Asia have been especially hard hit by the epidemic.
Increased urbanization, public health complacency and immunity-weakening HIV have been major enablers of TB's spread in recent decades. But the bacterium that causes TB Mycobacterium tuberculosis (Mtb) also happens to be unusually well adapted for persisting in humans. Among other strategies, it frequently reverts to a dormant, non-replicating state and also creates attack-resistant cell colonies called biofilms, which contain a high proportion of non-replicating TB.
Compared to ordinary, fast-replicating TB, these other forms of TB are much less susceptible to existing drugs. Effective TB therapy thus requires months to years of regular dosing. But many patients quit before completing such long courses of treatment and end up incubating drug-resistant TB strains. Some strains are now extensively drug-resistant (XDR) and virtually untreatable and usually fatal.
Killing the Persisters
The big challenge here has been to find a drug that clears TB infection more quickly, which means it has to be effective against both replicating and non-replicating TB, said Wang, now also a scientist at the California Institute for Biomedical Research (CALIBR), a non-profit organization founded by Schultz for the early-stage development of new medicines.
Most existing TB drugs work poorly against non-replicating TB, having been developed principally for their ability to kill actively replicating TB. Wang therefore set up a different kind of screening test one to detect compounds that block TB's persistence-related ability to form biofilms.
Because experiments with live TB require a special (level 3) biosafety facility, Wang used a related but non-disease-causing mycobacterium for his initial, high-throughput test. Screening a diverse library of 70,000 compounds, he quickly found one, dubbed TCA1, that stood out for its ability to inhibit mycobacterial biofilms.
Tests in Jacobs's biosafety level 3-certified laboratory confirmed that TCA1 also has powerful activity against TB. Surprisingly, it turned out to kill both non-replicating and replicating TB, Wang said.
In cell culture tests, TCA1 on its own killed more than 99.9% of ordinary, actively replicating TB bacteria within three weeks, and in combination with isoniazid or rifampin, could kill 100% within that period. TCA1 also showed strong effectiveness against drug-resistant TB strains, removing all signs of one common strain within a week when combined with isoniazid. Against a highly fatal super-bug strain from South Africa, which resists all conventional TB drugs, the new compound on its own had a kill rate of more than 99.999% within three weeks.
As expected, TCA1 also showed potent effects against non-replicating TB. Tests in mice confirmed TCA1's effectiveness and suggested that the combination of TCA1 and isoniazid could be more powerful than existing drug regimens. TCA1 showed no sign of toxicity or adverse side effects in cell culture and mouse experiments, and also showed almost no tendency to induce drug resistance in TB.
A Complex Mechanism
Working with the laboratories of Gurdyal S. Besra and Klaus F tterer at the University of Birmingham, UK, Katarina Mikusova at Comenius University in Slovakia, and Kai Johnson at Ecole Polytechnique F d rale de Lausanne (EPFL) in Switzerland, the team next did structural and biochemical analyses to determine how the new compound kills Mtb so efficiently.
The researchers found it works in an apparently unique way, largely by targeting two Mtb enzymes, one supporting TB replication and the other TB dormancy and persistence. I don't know of any other antibiotic that kills replicating bacteria through one pathway and non replicating bacteria through another, as this one does, Wang said.
Now funded by the Global Alliance for TB Drug Development, Wang and his colleagues are working to devise improved variants of TCA1. We already have analogs of TCA1 that are more potent and look very promising as TB drug candidates, said Wang.
Assuming that preclinical tests are completed successfully, he ad
Most recent headlines
05/01/2027
Worlds first 802.15.4ab-UWB chip verified by Calterah and Rohde & Schwarz to be ...
16/11/2026
The ESPN Edge Innovation Conference once again gave key ESPN technology partners as a chance to take to the stage and discuss the future of sports fan experienc...
16/11/2026
As rights holders rethink who tells their stories and where, IMG is preparing th...
16/11/2026
From the sidelines, sonic savants advocate for greater emphasis on sound as sports and entertainment increasingly merge
SVG Live!, a one-day event on Nov. 10 i...
16/11/2026
Deal combines Yamaha's audio technology with Disguise's visual-productio...
16/11/2026
Creative effects designed to encourage experimentation
Berry Effects is the brainchild of Abe and Ralph, a pair of multi-instrumentalists and audio engineer...
16/11/2026
Physics-based synth gets first major update
Anukari have just released a new version of their innovative physics-based software synth, marking the instrumen...
16/11/2026
Both versions kitted out with new tools & improvements
Hit'n'Mix have just launched the latest major version of their innovative DAW software, with ...
16/11/2026
Dynamic bands, unmasking features & new stereo tools
Launched in 2021, Eventide's SplitEQ plug-in introduced an interesting new approach to EQ, with the...
16/11/2026
Rohde & Schwarz Japan demonstrates multi-vendor ASA-ML communication with high p...
16/11/2026
November 16, 2026
Hitachi system enables proton beams to be delivered from 360 degrees around the patient, expanding treatment capacity and supporting more pre...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
16/11/2026
Hiltron Communications has received a repeat order from one of Europes longest established communications satellite operators. Central to this project is a Hilt...
16/11/2026
Fabric Insights and Fonn Group today announce a partnership to connect editorial planning and media operations across their complementary product portfolios.
...
16/11/2026
Density 1.0 brings a complete color grading workflow to Final Cut Pro
Brie Clayton November 16, 2026
0 Comments
Filmmaker Pascal Basel's plugin pr...
16/11/2026
Berklee Students to Perform at Boston's CITGO Sign Relighting Kuper Walker, Ollie Mann, and dreamcorp. will perform at the free public celebration in Kenm...
16/11/2026
The Hollywood Reporter Names Berklee Among World's Best Music Schools The annual list spotlights Berklee's screen scoring programs and new master'...
16/11/2026
Five years ago, Lightware launched the original Taurus UCX with a clear vision: USB-C would become the central connection in meeting rooms. The goal was simple:...
16/11/2026
Sonniss: bundles over 80% below their libraries' prices, plus up to 60% off ...
16/11/2026
Singaporean Comedy Luck My Life Shot with Blackmagic URSA Cine 17K 65
Brie Clayton November 16, 2026
0 Comments
Blackmagic PYXIS 12K and DaVinci Resol...
16/11/2026
Images available HERE
UKTV has announced Fleet Street (6x60'), a new period crime drama from Miss Scarlet creators Rachael New and Ben Edwards, coming to f...
16/11/2026
November 16th, 2026
TRIBECA FESTIVAL LISBOA UNVEILS 2026 FILM LINEUP AND TALE...
16/11/2026
From Graham Norton to Olivia Attwood and Joe Marler, a new collection of hit vid...
16/11/2026
As countries gather to discuss climate targets at COP 31 this week, one question that is at the heart of debates is how to measure the environmental impact of t...
16/11/2026
Announced today at SC26, NVIDIA Rubin HPC is a new GPU in the NVIDIA Vera Rubin ...
16/11/2026
This week at SC26, NVIDIA is marking two decades of CUDA by honoring the researchers, developers and engineers who helped make GPU computing a foundation for mo...
16/11/2026
With expanded NVIDIA CUDA-X libraries, including cuPhoton, cuPotential and cuSpa, researchers can sift through vast amounts of data to accelerate research, from...
16/11/2026
In its MLPerf benchmarks debut, with results released today, the NVIDIA Vera Rub...
16/11/2026
Quantum processor deployments at supercomputing centers have grown nearly sevenfold over the past five years, with nearly 30 supercomputing centers around the w...
16/11/2026
To train an AI model, thousands of GPUs have to work together, requiring a network that's fast, efficient and resilient.
Lambda is tackling the network pie...
15/11/2026
Mixers, interfaces & DAW controller receive new firmware
Yamaha have just launched a trio of firmware updates that bring some powerful new functionality to ...
15/11/2026
Can VideoProc AI Really Reduce Noise and Enhance Blurry, Old Footage? Real-World...
15/11/2026
Over two days at COEX, more than 2,000 attendees converged for AI Day Seoul, bri...
14/11/2026
Longtime MLB Network employee David Maybrown passed away Thursday at the age of 57. David joined MLB Network in 2009 shortly after its launch, beginning as an i...
14/11/2026
Modular innovators introduce two guitar-based products
ADDAC System's recently introduced Four String Series makes it possible to integrate physical str...
14/11/2026
Marcelo Dai's Live Session Captured with URSA Cine Immersive
Brie Clayton November 14, 2026
0 Comments
Artist takes viewers on an immersive journe...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Share
{alert(Link copied)}).catch(err => {console.error(Failed to copy: , err)}) data-platform=copy_link data-action= class=font-ui-heading py-2 text-sm tex...
14/11/2026
Newest Lenses, Horizon Anamorphic Seminar & Guided Lens Character Experience Highlight Creative Possibilities
At the 2026 Toru CAMERIMAGE Film Festival, ZEISS...
14/11/2026
Sonnet Announces Black Friday Sale on Select Products
Brie Clayton November 14, 2026
0 Comments
WHAT: Sonnet Technologies is having a sale on a select...
14/11/2026
Berklee Alumni Shine at the 2026 Latin Grammy Awards This year's winners included songwriters, engineers, and performers who contributed to acclaimed reco...
13/11/2026
The UIM E1 Series wraps its third season this week with the Bombay Sapphire E1 Miami GP, Nov. 11-14, on Biscayne Bay at the Miami Seaplane Base on Watson Island...
13/11/2026
In-venue and creative video staffers at the professional and collegiate level ha...